Why Teva Pharmaceutical Is Crashing Today
After the company provided investors with yet another disappointing update to its financial performance, shares in Teva Pharmaceutical (NYSE: TEVA) are losing 15% as of 1 p.m. EDT.
It's been tough going in 2017 for the world's biggest generic drugmaker, and unfortunately, investors hoping that the worst was behind the company earlier this year may have to settle in and expect some more rockiness.
IMAGE SOURCE: GETTY IMAGES.
Source: Fool.com
Teva Pharmaceutical Industries Ltd ADR Stock
€29.60
-1.330%
The stock is an absolute favorite of our community with 23 Buy predictions and no Sell predictions.
As a result the target price of 34 € shows a slightly positive potential of 14.86% compared to the current price of 29.6 € for Teva Pharmaceutical Industries Ltd ADR.
